» Articles » PMID: 36294555

Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease

Overview
Journal J Fungi (Basel)
Date 2022 Oct 27
PMID 36294555
Authors
Affiliations
Soon will be listed here.
Abstract

The majority of human coccidioidomycosis infections are asymptomatic or self-limited but may have sequestered spherules in highly structured granulomas. Under immunosuppression, reactivation of fungal growth can result in severe disease. B6D2F1 mice asymptomatically infected with C. posadasii strain 1038 were immunosuppressed with dexamethasone (DXM) in drinking water. Treated mice died 16−25 days later, while untreated mice survived (p < 0.001). Flow cytometry of lung granulomas on days 5, 10, 15, and 20 of DXM treatment showed immune cell populations decreased 0.5−1 log compared with untreated mice though neutrophils and CD19+IgD−IgM− cells rebounded by day 20. Histopathology demonstrated loss of granuloma structure by day 5 and increasing spherules through day 20. On day 20, T-cells were nearly absent and disorganized pyogranulomatous lesions included sheets of plasma cells and innumerable spherules. Mice given DXM for 14 days then stopped (DXM stop) survived 6 weeks (9/10). Lung fungal burdens were significantly lower (p = 0.0447) than mice that continued treatment (DXM cont) but higher than untreated mice. Histopathologically, DXM stop mice did not redevelop controlled granulomas by sacrifice, though T-cells were densely scattered throughout the lesions. This demonstrates a mouse model suitable for further study to understand the immunologic components responsible for maintenance control of coccidioidomycosis.

Citing Articles

From soil to clinic: current advances in understanding and coccidioidomycosis.

Jackson K, Teixeira M, Barker B Microbiol Mol Biol Rev. 2024; 88(4):e0016123.

PMID: 39365073 PMC: 11653724. DOI: 10.1128/mmbr.00161-23.


The Known and Unknown "Knowns" of Human Susceptibility to Coccidioidomycosis.

Hsu A J Fungi (Basel). 2024; 10(4).

PMID: 38667927 PMC: 11051025. DOI: 10.3390/jof10040256.


Coccidioidomycosis Granulomas Informed by Other Diseases: Advancements, Gaps, and Challenges.

Miranda N, Hoyer K J Fungi (Basel). 2023; 9(6).

PMID: 37367586 PMC: 10301931. DOI: 10.3390/jof9060650.

References
1.
Shubitz L, Powell D, Butkiewicz C, Lewis M, Trinh H, Frelinger J . A Chronic Murine Disease Model of Coccidioidomycosis Using Coccidioides posadasii, Strain 1038. J Infect Dis. 2020; 223(1):166-173. PMC: 7781464. DOI: 10.1093/infdis/jiaa419. View

2.
Shubitz L, Dial S, Perrill R, Casement R, Galgiani J . Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii. Infect Immun. 2008; 76(12):5553-64. PMC: 2583549. DOI: 10.1128/IAI.00885-08. View

3.
Ma F, Hughes T, Teles R, Andrade P, Silva B, Plazyo O . The cellular architecture of the antimicrobial response network in human leprosy granulomas. Nat Immunol. 2021; 22(7):839-850. PMC: 8579511. DOI: 10.1038/s41590-021-00956-8. View

4.
Sachdeva M, Ronaghi R, Mills P, Peterson M . Complications and Yield of Computed Tomography-Guided Transthoracic Core Needle Biopsy of Lung Nodules at a High-Volume Academic Center in an Endemic Coccidioidomycosis Area. Lung. 2016; 194(3):379-85. DOI: 10.1007/s00408-016-9866-3. View

5.
Modlin R, Gebhard J, Taylor C, Rea T . In situ characterization of T lymphocyte subsets in the reactional states of leprosy. Clin Exp Immunol. 1983; 53(1):17-24. PMC: 1535549. View